MS decreases the larger amplitude distribution in adult rats. by Jesús David Ayala-Rodríguez (17364296)

Change in Demoralization Scale (DSII) by Treatment Group. by Benjamin R. Lewis (22279166)

Subjects:

Top-down diagram of the Quinlan Brothers Ltd. seafood processing plant in 2022 (not to scale). by Tori V. Burt (17261197)

Subjects:

Change in Watt’s Connectedness Scale, Subscales by Treatment Group. by Benjamin R. Lewis (22279166)

Subjects:

Change in Watt’s Connectedness Scale (WCS), General Connectedness by Treatment Group. by Benjamin R. Lewis (22279166)

Subjects:

Matrix crosslinking decreases cell migration persistence. by Michael Pamonag (12295175)

A noxious temperature decrease without a prior increase produces a subtly larger decrease in pain intensity. by Benedict J. Alter (9745466)

Correlations of cytokines that significantly change between the pre-infusion and post-infusion blood draws pearson’s correlation between cytokine pairs is indicated by color and si... by Jordan K. Abbott (8934239)

Subjects:

Comparison of the study groups in terms of the mean score of VAS scale, on days 1,7,10, and 14 post-intervention. by Masoumeh Sayahi (17468290)

Subjects:

Comparison of the study groups in terms of the mean score of REEDA scale, on days 1,7,10 and 14 post-intervention. by Masoumeh Sayahi (17468290)

Subjects:

Larger example of stimuli with cue relevant for Task 3. by Marcel F. Hinss (14675457)

Long COVID prevalence decreases with vaccine uptake in the U.S. by Manlio De Domenico (626037)

“…<p>(A) Prevalence in U.S. states and the U.S. exhibits a decreasing trend with respect to vaccine uptake, both in the population vaccinated with at least one dose (top) and two doses (bottom), with the largest gap between 100% vaccinated and 100% unvaccinated scenarios observed in the reference population of adults who had COVID-19. …”

Scaled cross-fiber areas (CSA_fib,_scaled) are significantly reduced in the CP cohort, indicating a reduced maximum force and functional weakness for this muscle. by Annika S. Sahrmann (6396938)

Barriers, facilitators, and recommendations to scale up MDR. by Rachel Hennein (9565030)

Subjects:

Points represent regions where the cluster coefficient was significantly larger in HC compared to MCI, at sparsity level of 0.15. by Therese M. Gilligan (7460906)

Flowchart of study participants. by Masoumeh Sayahi (17468290)

Subjects:

Examination of the effect of treatment groups, different times and the effect of group* time, for VAS and REEDA indicators. by Masoumeh Sayahi (17468290)

Subjects:

Comparison of sociodemographic characteristics of participants in two groups of intervention and control. by Masoumeh Sayahi (17468290)

Subjects:

Decrease of injuries. by Petr Fulin (8380320)

Subjects:

Example of predicted effects of choice bundling on preference for larger, later rewards (LLRs) over smaller, sooner rewards (SSRs). by Jeffrey S. Stein (11689918)